感染新的严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）导致以前未知的临床表现，它被称为COVID-19（2019年冠状病毒病），最早在中国湖北地区被描述。SARS-CoV-2大流行对医学的所有领域都有影响。它直接和间接地影响神经系统疾病的护理。SARS-CoV-2感染可能与脑病和脑脊髓炎等神经系统表现的发生率增加有关，缺血性中风和脑出血，嗅觉缺失和神经肌肉疾病。2020年10月，德国神经病学会(DGN，DeutscheGesellschaftfürNeurologie）发布了有关新感染的神经系统表现的第一份指南。本S1指南为SARS-CoV-2感染患者的神经系统表现提供了指导。有和没有SARS-CoV-2感染的神经系统疾病患者，以及对医护人员的保护。这是德国神经学会发布的指南的缩写版本，并在AWMF（科学医学协会工作组；ArbeitsgemeinschaftwissenschaftlicherMedizinischerFachgesellschaften）的指南存储库中发布。
Infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was first described in the Hubei region of China. The SARS-CoV-2 pandemic has implications for all areas of medicine. It directly and indirectly affects the care of neurological diseases. SARS-CoV-2 infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases. In October 2020, the German Society of Neurology (DGN, Deutsche Gesellschaft für Neurologie) published the first
guideline on the neurological manifestations of the new infection. This S1
guideline provides guidance for the care of patients with SARS-CoV-2 infection regarding neurological manifestations, patients with neurological disease with and without SARS-CoV-2 infection, and for the protection of healthcare workers. This is an abbreviated version of the
guideline issued by the German Neurological society and published in the
Guideline repository of the AWMF (Working Group of Scientific Medical Societies; Arbeitsgemeinschaft wissenschaftlicher Medizinischer Fachgesellschaften).
PDF(Sci-hub)